Rich-Garg, Neha
Danve, Abhijeet http://orcid.org/0000-0002-3032-0828
Choi, Dongseok
Vakil-Gilani, Kiana
Akkoc, Nurullah
Azevedo, Valderillo
Russell, Anthony
Sharma, Aman
Cush, John
Curtis, Jeffery R.
Deodhar, Atul
Funding for this research was provided by:
Pfizer Foundation
Article History
Received: 8 April 2020
Revised: 27 June 2020
Accepted: 21 July 2020
First Online: 14 August 2020
Compliance with ethical standards
:
: Atul Deodhar—Advisory Boards and honoraria: AbbVie, Amgen, Boehringer Ingelheim, Celgene, Eli Lilly, Gilead, Glaxo Smith & Kline, Janssen, Novartis, Pfizer, and UCB.Research Grants: AbbVie, Eli Lilly, Glaxo Smith & Kline, Novartis, Pfizer, and UCB.Abhijeet Danve—Advisory boards and honoraria: Janssen.Research Grants: Novartis.Jeffrey R Curtis—Research grants: AbbVie, Amgen, BMS, Corrona, Eli Lilly, Janssen, Myriad, Pfizer, Regeneron, Roche, UCB; Consultancies: AbbVie, Amgen, BMS, Corrona, Eli Lilly, Janssen, Myriad, Pfizer, Regeneron, Roche, and UCB.Aman Sharma—None.Neha Rich-Garg—None.Dongseok Choi—None.Kiana Vakil-Gilani—None.Nurullah Akkoc—None.Valderillo Azevedo—Research grants: Pfizer, Roche, Janssen, Bristol, Abbvie, Medimmune, Boehringer-ingelheim, GSK, UCB, Sanofi, Takeda, and NovoNordisk.Speaker /honoraria—Pfizer, Hospira, Lilly, Amgen, MSD, BMS, Merck Serono, Janssen, Novartis, Celltrion, UCB, and AstraZeneca.Anthony Russell—None.John Cush—None.